Riskpilot← Back to searchSign inGet full accessSuperior Sweden AB
ABActiveOrg 5568574635Hangvar Skola 708Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20112 employees
Revenue 2025
SEK 537K
-37% vs 2024
EBITDA margin
-1.7%
-103% vs 2024
Equity ratio
32.8%
Financial strength
Net profit 2025
SEK -11K
-104% vs 2024
| Revenue | SEK 537K | -37% |
| EBITDA | SEK -9K | -103% |
| Net profit | SEK -11K | -104% |
| Total assets | SEK 187K | +5% |
| Equity | SEK 61K | -16% |
| Employees | 2 | — |
Legal name
Superior Sweden AB
Org number
5568574635
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30 juni 2011
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva tillverkning, inköp och försäljning av sjukvårds- och rehabiliteringsprodukter och därmed förenlig verksamhet.
Address
Hangvar Skola 708
Email
johan@superiorsweden.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 388 | 2 146 | 1 011 | 853 | 537 |
| Staff expenses | — | −955 | −1 008 | −43 | −212 |
| EBITDA | −134 | 136 | −630 | 326 | −9 |
| Depreciation & amort. | −0 | −48 | −98 | −3 | −2 |
| EBIT | −134 | 88 | −729 | 323 | −11 |
| Net financials | −1 | −7 | −17 | −5 | −0 |
| Profit before tax | −135 | 81 | −746 | 318 | −11 |
| Tax | −0 | — | — | — | — |
| Net profit | −135 | 81 | −746 | 318 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 637 | 717 | 511 | 178 | 187 |
| Equity | 170 | 251 | −495 | 73 | 61 |
| Long-term debt | 0 | 290 | 0 | — | — |
| Short-term debt | 467 | 176 | 1 006 | 105 | 126 |
| Total debt | 467 | 466 | 1 006 | 105 | 126 |
EBITDA margin
-1.7%
This company
15.8%
Market median
-111% vs market
20212025
Equity ratio
32.8%
This company
38.2%
Market median
+14% vs market
20212025
Return on equity
-18.6%
This company
18.4%
Market median
-201% vs market
20212025
Net profit margin
-2.1%
This company
8.1%
Market median
-126% vs market
20212025
Asset turnover
2.87×
This company
1.12×
Market median
+156% vs market
20212025
Debt / equity
2.05×
This company
0.62×
Market median
-231% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Superior Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Erik Melin | Board of Directors | 0 companies |
| Anna Birgitta Franklin | Deputy Board Member | 0 companies |
| Bo Erik Melin | Board of Directors | 0 companies |
| Erik Magnus Melin | Deputy Board Member | 0 companies |